Persistent Psychosis After a Single Ingestion of "Ecstasy" (MDMA)

Overview

Journal Prim Care Companion CNS Disord

Specialties Neurology
Psychiatry
Public Health

Date 2012 Mar 29

PMID 22454798

Citations 8

Authors

Ankit Patel

Toby Moreland

Fasiha Haq

Fatima Siddiqui

Melissa Mikul

Huma Qadir

Shakeel Raza

Affiliations

Soon will be listed here.

Citing Articles

Navigating Treatment Challenges: A Case Study on Refractory Psychosis in a Chronic MDMA (3,4-Methylenedioxymethamphetamine) User.

Litenski M, OReardon A, Pabon N, Hernandez M, Niyazov Y, Cruz J Cureus. 2024; 16(5):e59641.

PMID: 38832158 PMC: 11146661. DOI: 10.7759/cureus.59641.

Brain dysfunctions and neurotoxicity induced by psychostimulants in experimental models and humans: an overview of recent findings.

Serra M, Simola N, Pollack A, Costa G Neural Regen Res. 2024; 19(9):1908-1918.

PMID: 38227515 PMC: 11040293. DOI: 10.4103/1673-5374.390971.

MDMA for the Treatment of Negative Symptoms in Schizophrenia.

Arnovitz M, Spitzberg A, Davani A, Vadhan N, Holland J, Kane J J Clin Med. 2022; 11(12).

PMID: 35743326 PMC: 9225098. DOI: 10.3390/jcm11123255.

Attenuated Psychotic Symptoms in Adolescents With Chronic Cannabis and MDMA Use.

Wiedmann M, Kuitunen-Paul S, Basedow L, Roessner V, Golub Y Front Psychiatry. 2022; 12:696133.

PMID: 35126190 PMC: 8814345. DOI: 10.3389/fpsyt.2021.696133.

MDMA Abuse in Relation to MicroRNA Variation in Human Brain Ventral Tegmental Area and Nucleus Accumbens.

Demirel G, Guzel E, Creighton C, Erol Ozturk Y, Kucuk C, Asliyuksek H Iran J Pharm Res. 2020; 18(4):1989-1999.

PMID: 32184864 PMC: 7059052. DOI: 10.22037/ijpr.2019.15097.12874.

References

Potash M, Gordon K, Conrad K . Persistent Psychosis and Medical Complications After a Single Ingestion of MDMA "Ecstasy": A Case Report and Review of the Literature. Psychiatry (Edgmont). 2009; 6(7):40-4. PMC: 2728937. View

Morgan M . Ecstasy (MDMA): a review of its possible persistent psychological effects. Psychopharmacology (Berl). 2000; 152(3):230-48. DOI: 10.1007/s002130000545. View

Smith K, Larive L, Romanelli F . Club drugs: methylenedioxymethamphetamine, flunitrazepam, ketamine hydrochloride, and gamma-hydroxybutyrate. Am J Health Syst Pharm. 2002; 59(11):1067-76. DOI: 10.1093/ajhp/59.11.1067. View

Van Kampen J, Katz M . Persistent psychosis after a single ingestion of 'ecstasy'. Psychosomatics. 2002; 42(6):525-7. DOI: 10.1176/appi.psy.42.6.525. View

McGuire P, Fahy T . Chronic paranoid psychosis after misuse of MDMA ("ecstasy"). BMJ. 1991; 302(6778):697. PMC: 1669116. DOI: 10.1136/bmj.302.6778.697. View

Henry J, Jeffreys K, Dawling S . Toxicity and deaths from 3,4-methylenedioxymethamphetamine ("ecstasy"). Lancet. 1992; 340(8816):384-7. DOI: 10.1016/0140-6736(92)91469-o. View

Williams H, Meagher D, Galligan P . M.D.M.A. ("Ecstasy"); a case of possible drug-induced psychosis. Ir J Med Sci. 1993; 162(2):43-4. DOI: 10.1007/BF02942900. View

Schifano F . Chronic atypical psychosis associated with MDMA ("ecstasy") abuse. Lancet. 1991; 338(8778):1335. DOI: 10.1016/0140-6736(91)92633-d. View

Cohen R, Cocores J . Neuropsychiatric manifestations following the use of 3,4-methylenedioxymethamphetamine (MDMA: "Ecstasy"). Prog Neuropsychopharmacol Biol Psychiatry. 1997; 21(4):727-34. DOI: 10.1016/s0278-5846(97)00045-6. View

10.

Gouzoulis-Mayfrank E, Daumann J . Neurotoxicity of methylenedioxyamphetamines (MDMA; ecstasy) in humans: how strong is the evidence for persistent brain damage?. Addiction. 2006; 101(3):348-61. DOI: 10.1111/j.1360-0443.2006.01314.x. View

11.

Vecellio M, Schopper C, Modestin J . Neuropsychiatric consequences (atypical psychosis and complex-partial seizures) of ecstasy use: possible evidence for toxicity-vulnerability predictors and implications for preventative and clinical care. J Psychopharmacol. 2003; 17(3):342-5. DOI: 10.1177/02698811030173018. View

12.

Hurley R, Reneman L, Taber K . Ecstasy in the brain: a model for neuroimaging. J Neuropsychiatry Clin Neurosci. 2002; 14(2):125-9. DOI: 10.1176/jnp.14.2.125. View

13.

Thomasius R, Zapletalova P, Petersen K, Buchert R, Andresen B, Wartberg L . Mood, cognition and serotonin transporter availability in current and former ecstasy (MDMA) users: the longitudinal perspective. J Psychopharmacol. 2006; 20(2):211-25. DOI: 10.1177/0269881106059486. View